Clinical Trial Update: Blood-Brain Barrier Disruption Using Transcranial MRI-Guided Focused Ultrasound [NA]

View source ↗

Summary

The clinical trial examining blood-brain barrier disruption using transcranial MRI-guided focused ultrasound for brain tumors remains active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Snippet

Sponsor: InSightec | Conditions: Brain Tumor | NA | Status: ACTIVE_NOT_RECRUITING